This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
. Page versions: R5 R4B R4 R3
| Pharmacy Work Group | Maturity Level: N/A | Ballot Status: Informative | Compartments: Encounter, Patient, Practitioner |
Oral Chemotherapy Order - Myleran - completed - with reasonCode
{
"resourceType": "MedicationRequest",
"id": "medrx0306",
"text": {
"status": "generated",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: medrx0306</p><p><b>contained</b>: </p><p><b>identifier</b>: 12345689 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: Myleran 2mg tablet. Generated Summary: id: med0304; Myleran 2mg tablet, film coated <span>(Details : {http://hl7.org/fhir/sid/ndc code '76388-713-25' = '76388-713-25', given as 'Myleran 2mg tablet, film coated'})</span></p><p><b>subject</b>: <a>Donald Duck</a></p><p><b>authoredOn</b>: 15/01/2015</p><h3>Requesters</h3><table><tr><td>-</td><td><b>Agent</b></td><td><b>OnBehalfOf</b></td></tr><tr><td>*</td><td><a>Patrick Pump</a></td><td><a>Organization/f002</a></td></tr></table><p><b>reasonCode</b>: Chronic myeloid Leukemia (disorder) <span>(Details : {SNOMED CT code '92818009' = 'Chronic myeloid leukemia', given as 'Chronic myeloid Leukemia (disorder)'})</span></p><p><b>dosageInstruction</b>: </p></div>"
},
"contained": [
{
"resourceType": "Medication",
"id": "med0304",
"code": {
"coding": [
{
"system": "http://hl7.org/fhir/sid/ndc",
"code": "76388-713-25",
"display": "Myleran 2mg tablet, film coated"
}
]
}
}
],
"identifier": [
{
"use": "official",
"system": "http://www.bmc.nl/portal/prescriptions",
"value": "12345689"
}
],
"status": "active",
"intent": "order",
"medicationReference": {
"reference": "#med0304",
"display": "Myleran 2mg tablet"
},
"subject": {
"reference": "Patient/pat1",
"display": "Donald Duck"
},
"authoredOn": "2015-01-15",
"requester": {
"agent": {
"reference": "Practitioner/f007",
"display": "Patrick Pump"
},
"onBehalfOf": {
"reference": "Organization/f002"
}
},
"reasonCode": [
{
"coding": [
{
"system": "http://snomed.info/sct",
"code": "92818009",
"display": "Chronic myeloid Leukemia (disorder)"
}
]
}
],
"dosageInstruction": [
{
"sequence": 1,
"text": "6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL",
"timing": {
"repeat": {
"frequency": 1,
"period": 1,
"periodUnit": "d"
}
},
"route": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "26643006",
"display": "Oral route (qualifier value)"
}
]
},
"doseQuantity": {
"value": 6,
"unit": "mg",
"system": "http://unitsofmeasure.org",
"code": "mg"
}
}
]
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.